FDA Orphan Drug Designation for Bexmarilimab : vimarsana.com

 

Faron Pharmaceuticals Ltd.



 

 Inside Information:  Faron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid Leukemia

 


ODD further strengthens bexmarilimab program...

Related Keywords

Massachusetts , United States , Finland , Boston , Jukka , Lapland , Christopher Golden , Jenniferc Smith Parker , Juha Karttunen , Jo Turner , Sandy Jamieson , Peel Hunt , Drug Administration , Faron Pharmaceuticals Ltd , Company Announcement , Head Of Communications , Cairn Financial Advisers , Office Of Orphan Drug Products , Faron Pharmaceuticals , Faron Receives , Drug Designation , Acute Myeloid , First North , Orphan Drug Designation , Orphan Drug Products , Chief Medical Officer , Certified Adviser , Nasdaq First , Markets ,